Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_STR,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,0.94 [0.9-0.98],0.00130032700528145,cis
Chapter IX Diseases of the circulatory system,I9_STR,APOC1,Apolipoprotein C-I,Inverse variance weighted,6,1.32 [1.1-1.58],0.00319162654993763,cis
Chapter IX Diseases of the circulatory system,I9_STR,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.11 [1.03-1.19],0.00359563375694671,cis
Chapter IX Diseases of the circulatory system,I9_STR,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.69 [0.54-0.89],0.00388877863491515,cis
Chapter IX Diseases of the circulatory system,I9_STR,ITGAV,Integrin alpha-V,Inverse variance weighted,5,1.21 [1.06-1.39],0.00482394110329019,cis
Chapter IX Diseases of the circulatory system,I9_STR,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,1.04 [1.01-1.08],0.00500699536484058,cis
Chapter IX Diseases of the circulatory system,I9_STR,EDN1,Endothelin-1,Inverse variance weighted,3,0.89 [0.82-0.97],0.00699524203517939,cis
Chapter IX Diseases of the circulatory system,I9_STR,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,0.88 [0.8-0.97],0.00728954293332275,cis
Chapter IX Diseases of the circulatory system,I9_STR,C7,Complement component C7,Inverse variance weighted,38,1.03 [1.01-1.06],0.00831354398988919,cis
Chapter IX Diseases of the circulatory system,I9_STR,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,1.05 [1.01-1.09],0.00852539955666362,cis
Chapter IX Diseases of the circulatory system,I9_STR,THBS2,Thrombospondin-2,Inverse variance weighted,16,0.94 [0.9-0.98],0.00853582062014448,cis
Chapter IX Diseases of the circulatory system,I9_STR,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,1.05 [1.01-1.08],0.0101316090769575,cis
Chapter IX Diseases of the circulatory system,I9_STR,CST3,Cystatin-C,Inverse variance weighted,10,1.08 [1.02-1.14],0.0108272047294907,cis
Chapter IX Diseases of the circulatory system,I9_STR,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,0.95 [0.91-0.99],0.0128566107689629,cis
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.05 [1.01-1.09],0.0139652357515766,cis
Chapter IX Diseases of the circulatory system,I9_STR,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,1.08 [1.01-1.14],0.0153911145733669,cis
Chapter IX Diseases of the circulatory system,I9_STR,PLIN3,Perilipin-3,Wald ratio,1,0.73 [0.56-0.94],0.0165610533942756,cis
Chapter IX Diseases of the circulatory system,I9_STR,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,0.94 [0.88-0.99],0.0246372328670992,cis
Chapter IX Diseases of the circulatory system,I9_STR,CD302,CD302 antigen,Inverse variance weighted,9,0.92 [0.85-0.99],0.0282883357921938,cis
Chapter IX Diseases of the circulatory system,I9_STR,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,0.93 [0.88-0.99],0.0288435961379847,cis
Chapter IX Diseases of the circulatory system,I9_STR,COLEC12,Collectin-12,Inverse variance weighted,11,0.92 [0.86-0.99],0.0302111296216519,cis
Chapter IX Diseases of the circulatory system,I9_STR,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1.19 [1.02-1.4],0.0319803861937987,cis
Chapter IX Diseases of the circulatory system,I9_STR,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,8,0.86 [0.75-0.99],0.033498987319513,cis
Chapter IX Diseases of the circulatory system,I9_STR,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.94 [0.89-1],0.033959687086555,cis
Chapter IX Diseases of the circulatory system,I9_STR,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,7,0.96 [0.93-1],0.0341783971114,cis
Chapter IX Diseases of the circulatory system,I9_STR,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,0.85 [0.72-0.99],0.0358518065873907,cis
Chapter IX Diseases of the circulatory system,I9_STR,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.14 [1.01-1.29],0.036541943956661,cis
Chapter IX Diseases of the circulatory system,I9_STR,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.92 [0.85-1],0.0415960322005779,cis
Chapter IX Diseases of the circulatory system,I9_STR,DSC2,Desmocollin-2,Inverse variance weighted,9,0.93 [0.87-1],0.0419224393329606,cis
Chapter IX Diseases of the circulatory system,I9_STR,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,0.94 [0.89-1],0.0429506632301485,cis
Chapter IX Diseases of the circulatory system,I9_STR,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.12 [1-1.25],0.0432780043849228,cis
Chapter IX Diseases of the circulatory system,I9_STR,CA4,Carbonic anhydrase 4,Inverse variance weighted,12,1.06 [1-1.11],0.0439663020421051,cis
Chapter IX Diseases of the circulatory system,I9_STR,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,0.95 [0.9-1],0.0450263990926935,cis
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.18 [1-1.39],0.0465563649113312,cis
Chapter IX Diseases of the circulatory system,I9_STR,GUCA2A,Guanylin,Inverse variance weighted,9,1.1 [1-1.2],0.0468728866712372,cis
Chapter IX Diseases of the circulatory system,I9_STR,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.89 [0.79-1],0.047633768700562,cis
Chapter IX Diseases of the circulatory system,I9_STR,CD83,CD83 antigen,Inverse variance weighted,5,1.1 [1-1.21],0.0503208238804166,cis
Chapter IX Diseases of the circulatory system,I9_STR,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,7,0.9 [0.81-1],0.0524924113898539,cis
Chapter IX Diseases of the circulatory system,I9_STR,APOA2,Apolipoprotein A-II,Wald ratio,1,0.75 [0.57-1.01],0.0558638061000804,cis
Chapter IX Diseases of the circulatory system,I9_STR,NECTIN4,Nectin-4,Inverse variance weighted,7,0.95 [0.9-1],0.0665409174502472,cis
Chapter IX Diseases of the circulatory system,I9_STR,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.16 [0.99-1.36],0.0678930010480714,cis
Chapter IX Diseases of the circulatory system,I9_STR,PI3,Elafin,Inverse variance weighted,10,1.06 [1-1.13],0.068391587685025,cis
Chapter IX Diseases of the circulatory system,I9_STR,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,0.97 [0.93-1],0.0687855693232017,cis
Chapter IX Diseases of the circulatory system,I9_STR,EFNA1,Ephrin-A1,Inverse variance weighted,11,0.95 [0.9-1],0.069818418932497,cis
Chapter IX Diseases of the circulatory system,I9_STR,CCN5,CCN family member 5,Inverse variance weighted,8,0.87 [0.75-1.02],0.0778784814354923,cis
Chapter IX Diseases of the circulatory system,I9_STR,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.92 [0.83-1.01],0.0871487533797379,cis
Chapter IX Diseases of the circulatory system,I9_STR,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.84 [0.68-1.03],0.0897434712587402,cis
Chapter IX Diseases of the circulatory system,I9_STR,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.31 [0.96-1.79],0.0918894563500111,cis
Chapter IX Diseases of the circulatory system,I9_STR,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,0.96 [0.91-1.01],0.092619902490593,cis
Chapter IX Diseases of the circulatory system,I9_STR,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,1.05 [0.99-1.12],0.0955004338736755,cis
Chapter IX Diseases of the circulatory system,I9_STR,LGALS4,Galectin-4,Inverse variance weighted,4,0.91 [0.81-1.02],0.104948871706521,cis
Chapter IX Diseases of the circulatory system,I9_STR,SPON1,Spondin-1,Inverse variance weighted,21,1.04 [0.99-1.09],0.114249877533924,cis
Chapter IX Diseases of the circulatory system,I9_STR,CCN3,CCN family member 3,Inverse variance weighted,19,1.05 [0.99-1.12],0.11670284945465,cis
Chapter IX Diseases of the circulatory system,I9_STR,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,0.96 [0.92-1.01],0.118476945235245,cis
Chapter IX Diseases of the circulatory system,I9_STR,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.05 [0.99-1.11],0.131129464163891,cis
Chapter IX Diseases of the circulatory system,I9_STR,F10,Coagulation factor X,Inverse variance weighted,9,1.03 [0.99-1.07],0.131974431354968,cis
Chapter IX Diseases of the circulatory system,I9_STR,REN,Renin,Inverse variance weighted,4,1.05 [0.98-1.13],0.135664969950197,cis
Chapter IX Diseases of the circulatory system,I9_STR,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.02 [0.99-1.05],0.136857908626465,cis
Chapter IX Diseases of the circulatory system,I9_STR,DKK3,Dickkopf-related protein 3,Inverse variance weighted,13,1.05 [0.98-1.11],0.144207781822965,cis
Chapter IX Diseases of the circulatory system,I9_STR,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,0.96 [0.92-1.01],0.147845403728289,cis
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.24 [0.92-1.66],0.151825847733872,cis
Chapter IX Diseases of the circulatory system,I9_STR,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.1 [0.96-1.25],0.158311715103374,cis
Chapter IX Diseases of the circulatory system,I9_STR,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,0.97 [0.92-1.01],0.158838467847473,cis
Chapter IX Diseases of the circulatory system,I9_STR,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,0.94 [0.86-1.03],0.160206622984822,cis
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.08 [0.97-1.19],0.16039432549737,cis
Chapter IX Diseases of the circulatory system,I9_STR,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,1.05 [0.98-1.13],0.16829172702171,cis
Chapter IX Diseases of the circulatory system,I9_STR,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,0.96 [0.91-1.02],0.172966100451928,cis
Chapter IX Diseases of the circulatory system,I9_STR,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,0.93 [0.83-1.03],0.175368852938501,cis
Chapter IX Diseases of the circulatory system,I9_STR,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,1.07 [0.97-1.18],0.182174060455173,cis
Chapter IX Diseases of the circulatory system,I9_STR,LGALS3,Galectin-3,Inverse variance weighted,25,1.03 [0.99-1.07],0.183960300026376,cis
Chapter IX Diseases of the circulatory system,I9_STR,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,0.95 [0.88-1.03],0.186044810262335,cis
Chapter IX Diseases of the circulatory system,I9_STR,IL15,Interleukin-15,Wald ratio,1,3.17 [0.57-17.65],0.187615528764543,cis
Chapter IX Diseases of the circulatory system,I9_STR,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,8,1.05 [0.98-1.13],0.190422643193564,cis
Chapter IX Diseases of the circulatory system,I9_STR,KLK4,Kallikrein-4,Inverse variance weighted,17,1.03 [0.98-1.08],0.190864023893866,cis
Chapter IX Diseases of the circulatory system,I9_STR,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.18 [0.92-1.52],0.196147205235988,cis
Chapter IX Diseases of the circulatory system,I9_STR,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.05 [0.98-1.12],0.201339876235584,cis
Chapter IX Diseases of the circulatory system,I9_STR,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.03 [0.99-1.07],0.202065663499021,cis
Chapter IX Diseases of the circulatory system,I9_STR,LGALS9,Galectin-9,Inverse variance weighted,26,1.03 [0.99-1.07],0.203161194079619,cis
Chapter IX Diseases of the circulatory system,I9_STR,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.75 [0.49-1.17],0.204681954233094,cis
Chapter IX Diseases of the circulatory system,I9_STR,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.82 [0.61-1.11],0.206706148009529,cis
Chapter IX Diseases of the circulatory system,I9_STR,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,1.03 [0.98-1.09],0.210841455061484,cis
Chapter IX Diseases of the circulatory system,I9_STR,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,0.92 [0.8-1.05],0.222390278706572,cis
Chapter IX Diseases of the circulatory system,I9_STR,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,0.95 [0.87-1.03],0.22338488841771,cis
Chapter IX Diseases of the circulatory system,I9_STR,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.92 [0.81-1.05],0.224666591970599,cis
Chapter IX Diseases of the circulatory system,I9_STR,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1.02 [0.99-1.06],0.226463690190581,cis
Chapter IX Diseases of the circulatory system,I9_STR,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.12 [0.93-1.33],0.231614962825561,cis
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.96 [0.9-1.03],0.234133047784136,cis
Chapter IX Diseases of the circulatory system,I9_STR,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.97 [0.93-1.02],0.239809832533221,cis
Chapter IX Diseases of the circulatory system,I9_STR,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.08 [0.95-1.23],0.246203968506388,cis
Chapter IX Diseases of the circulatory system,I9_STR,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.01 [0.99-1.04],0.246256547485441,cis
Chapter IX Diseases of the circulatory system,I9_STR,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.77 [0.49-1.2],0.246991251987514,cis
Chapter IX Diseases of the circulatory system,I9_STR,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,0.95 [0.87-1.04],0.248527867825443,cis
Chapter IX Diseases of the circulatory system,I9_STR,APCS,Serum amyloid P-component,Inverse variance weighted,4,1.04 [0.97-1.12],0.251982717938505,cis
Chapter IX Diseases of the circulatory system,I9_STR,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,1.04 [0.97-1.12],0.256376339079253,cis
Chapter IX Diseases of the circulatory system,I9_STR,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,0.97 [0.91-1.02],0.257379147766221,cis
Chapter IX Diseases of the circulatory system,I9_STR,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.08 [0.95-1.23],0.264154695250742,cis
Chapter IX Diseases of the circulatory system,I9_STR,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,1.34 [0.8-2.25],0.269247350704176,cis
Chapter IX Diseases of the circulatory system,I9_STR,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.04 [0.97-1.11],0.271638681253728,cis
Chapter IX Diseases of the circulatory system,I9_STR,GRN,Progranulin,Inverse variance weighted,7,1.05 [0.96-1.14],0.272207814813176,cis
Chapter IX Diseases of the circulatory system,I9_STR,HGF,Hepatocyte growth factor,Inverse variance weighted,2,1.12 [0.91-1.39],0.274546322269518,cis
Chapter IX Diseases of the circulatory system,I9_STR,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,0.95 [0.86-1.04],0.276519220502034,cis
Chapter IX Diseases of the circulatory system,I9_STR,NPPC,C-type natriuretic peptide,Wald ratio,1,1.28 [0.81-2.02],0.293398384200088,cis
Chapter IX Diseases of the circulatory system,I9_STR,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1.01 [0.99-1.03],0.303351175313331,cis
Chapter IX Diseases of the circulatory system,I9_STR,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,1.02 [0.98-1.06],0.308202620680592,cis
Chapter IX Diseases of the circulatory system,I9_STR,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.92 [0.77-1.08],0.310693039760572,cis
Chapter IX Diseases of the circulatory system,I9_STR,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,26,1.02 [0.98-1.07],0.312622017715187,cis
Chapter IX Diseases of the circulatory system,I9_STR,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,1.05 [0.95-1.16],0.31682637262783,cis
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1.03 [0.98-1.08],0.317038157347615,cis
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,0.93 [0.81-1.07],0.32362698505436,cis
Chapter IX Diseases of the circulatory system,I9_STR,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.04 [0.96-1.12],0.326211330398005,cis
Chapter IX Diseases of the circulatory system,I9_STR,PALM,Paralemmin-1,Inverse variance weighted,6,1.05 [0.95-1.17],0.334883575963161,cis
Chapter IX Diseases of the circulatory system,I9_STR,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.94 [0.83-1.07],0.335334618248453,cis
Chapter IX Diseases of the circulatory system,I9_STR,VWC2,Brorin,Inverse variance weighted,22,0.98 [0.93-1.03],0.336148059061583,cis
Chapter IX Diseases of the circulatory system,I9_STR,ITGA11,Integrin alpha-11,Inverse variance weighted,8,1.03 [0.97-1.1],0.343255465951057,cis
Chapter IX Diseases of the circulatory system,I9_STR,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,27,1.01 [0.99-1.04],0.345092628363542,cis
Chapter IX Diseases of the circulatory system,I9_STR,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,0.94 [0.83-1.07],0.354333712359741,cis
Chapter IX Diseases of the circulatory system,I9_STR,NID1,Nidogen-1,Inverse variance weighted,6,0.97 [0.9-1.04],0.35451632547904,cis
Chapter IX Diseases of the circulatory system,I9_STR,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.98 [0.92-1.03],0.355764841228704,cis
Chapter IX Diseases of the circulatory system,I9_STR,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,0.95 [0.84-1.07],0.358679297749812,cis
Chapter IX Diseases of the circulatory system,I9_STR,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,0.98 [0.94-1.02],0.362579687755275,cis
Chapter IX Diseases of the circulatory system,I9_STR,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1.02 [0.98-1.06],0.365104447530406,cis
Chapter IX Diseases of the circulatory system,I9_STR,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,1.01 [0.99-1.04],0.372173719906593,cis
Chapter IX Diseases of the circulatory system,I9_STR,NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.95 [0.86-1.06],0.377336847440698,cis
Chapter IX Diseases of the circulatory system,I9_STR,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,1.03 [0.96-1.12],0.380275975133713,cis
Chapter IX Diseases of the circulatory system,I9_STR,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.96 [0.88-1.05],0.381153960625158,cis
Chapter IX Diseases of the circulatory system,I9_STR,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,0.98 [0.93-1.03],0.38426467956518,cis
Chapter IX Diseases of the circulatory system,I9_STR,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.83 [0.54-1.27],0.38652234870406,cis
Chapter IX Diseases of the circulatory system,I9_STR,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.03 [0.97-1.09],0.386530575661083,cis
Chapter IX Diseases of the circulatory system,I9_STR,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,0.99 [0.96-1.02],0.39115389042474,cis
Chapter IX Diseases of the circulatory system,I9_STR,LAYN,Layilin,Inverse variance weighted,20,1.02 [0.97-1.08],0.392464169182258,cis
Chapter IX Diseases of the circulatory system,I9_STR,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,0.99 [0.96-1.02],0.396298258992943,cis
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.98 [0.94-1.03],0.396486457426404,cis
Chapter IX Diseases of the circulatory system,I9_STR,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.09 [0.89-1.35],0.397411990216938,cis
Chapter IX Diseases of the circulatory system,I9_STR,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,1.04 [0.95-1.13],0.399114190422169,cis
Chapter IX Diseases of the circulatory system,I9_STR,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,1.05 [0.93-1.19],0.403820153164446,cis
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.96 [0.86-1.06],0.404450804725427,cis
Chapter IX Diseases of the circulatory system,I9_STR,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,1.08 [0.9-1.29],0.404957048505522,cis
Chapter IX Diseases of the circulatory system,I9_STR,NUCB2,Nucleobindin-2,Inverse variance weighted,24,0.98 [0.94-1.03],0.416455928613303,cis
Chapter IX Diseases of the circulatory system,I9_STR,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,1.02 [0.98-1.06],0.420675764570684,cis
Chapter IX Diseases of the circulatory system,I9_STR,SPON2,Spondin-2,Inverse variance weighted,4,1.03 [0.95-1.12],0.423985245861349,cis
Chapter IX Diseases of the circulatory system,I9_STR,TNC,Tenascin,Inverse variance weighted,12,0.98 [0.92-1.04],0.427886931923121,cis
Chapter IX Diseases of the circulatory system,I9_STR,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1.04 [0.95-1.13],0.428204814626605,cis
Chapter IX Diseases of the circulatory system,I9_STR,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,0.99 [0.96-1.02],0.428363206181056,cis
Chapter IX Diseases of the circulatory system,I9_STR,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,1.03 [0.96-1.1],0.428904202156473,cis
Chapter IX Diseases of the circulatory system,I9_STR,AMBP,Protein AMBP,Inverse variance weighted,3,1.08 [0.9-1.3],0.431098906713029,cis
Chapter IX Diseases of the circulatory system,I9_STR,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.94 [0.81-1.1],0.4381419656705,cis
Chapter IX Diseases of the circulatory system,I9_STR,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,12,1.02 [0.97-1.07],0.449901112284572,cis
Chapter IX Diseases of the circulatory system,I9_STR,KLK11,Kallikrein-11,Inverse variance weighted,6,1.03 [0.96-1.1],0.450022976305214,cis
Chapter IX Diseases of the circulatory system,I9_STR,OCLN,Occludin,Inverse variance weighted,2,1.09 [0.87-1.38],0.451591137196071,cis
Chapter IX Diseases of the circulatory system,I9_STR,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.07 [0.9-1.27],0.455916986457566,cis
Chapter IX Diseases of the circulatory system,I9_STR,BCAN,Brevican core protein,Inverse variance weighted,3,0.97 [0.9-1.05],0.456502713169426,cis
Chapter IX Diseases of the circulatory system,I9_STR,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.03 [0.95-1.12],0.457282312711417,cis
Chapter IX Diseases of the circulatory system,I9_STR,PGF,Placenta growth factor,Inverse variance weighted,2,1.34 [0.61-2.94],0.459135160705913,cis
Chapter IX Diseases of the circulatory system,I9_STR,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1.01 [0.98-1.05],0.461177625538812,cis
Chapter IX Diseases of the circulatory system,I9_STR,FAM3B,Protein FAM3B,Inverse variance weighted,18,0.99 [0.95-1.02],0.472709664603268,cis
Chapter IX Diseases of the circulatory system,I9_STR,NECTIN2,Nectin-2,Inverse variance weighted,5,0.96 [0.87-1.07],0.47344993451533,cis
Chapter IX Diseases of the circulatory system,I9_STR,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,1.05 [0.92-1.18],0.475514773927725,cis
Chapter IX Diseases of the circulatory system,I9_STR,MDK,Midkine,Inverse variance weighted,4,1.07 [0.89-1.29],0.477274366598935,cis
Chapter IX Diseases of the circulatory system,I9_STR,BSG,Basigin,Wald ratio,1,1.05 [0.92-1.21],0.477526601148994,cis
Chapter IX Diseases of the circulatory system,I9_STR,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,0.82 [0.47-1.43],0.478883469890279,cis
Chapter IX Diseases of the circulatory system,I9_STR,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,0.9 [0.67-1.21],0.479894348592009,cis
Chapter IX Diseases of the circulatory system,I9_STR,SIAE,Sialate O-acetylesterase,Inverse variance weighted,3,0.97 [0.89-1.06],0.479962636265579,cis
Chapter IX Diseases of the circulatory system,I9_STR,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,1.09 [0.86-1.37],0.483554616487369,cis
Chapter IX Diseases of the circulatory system,I9_STR,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,0.99 [0.95-1.02],0.485171327582817,cis
Chapter IX Diseases of the circulatory system,I9_STR,UMOD,Uromodulin,Inverse variance weighted,29,0.99 [0.97-1.02],0.48644354019851,cis
Chapter IX Diseases of the circulatory system,I9_STR,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.94 [0.79-1.12],0.491843506021052,cis
Chapter IX Diseases of the circulatory system,I9_STR,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.99 [0.95-1.03],0.500844225916242,cis
Chapter IX Diseases of the circulatory system,I9_STR,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,0.93 [0.76-1.14],0.50481494501142,cis
Chapter IX Diseases of the circulatory system,I9_STR,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,1.01 [0.98-1.04],0.505807648916254,cis
Chapter IX Diseases of the circulatory system,I9_STR,ANG,Angiogenin,Inverse variance weighted,19,1.02 [0.97-1.07],0.507589856209898,cis
Chapter IX Diseases of the circulatory system,I9_STR,CHGA,Chromogranin-A,Inverse variance weighted,3,0.95 [0.81-1.11],0.511507254358814,cis
Chapter IX Diseases of the circulatory system,I9_STR,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.97 [0.89-1.06],0.512257478562029,cis
Chapter IX Diseases of the circulatory system,I9_STR,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1.02 [0.96-1.08],0.516501790370031,cis
Chapter IX Diseases of the circulatory system,I9_STR,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.96 [0.85-1.09],0.517113860975065,cis
Chapter IX Diseases of the circulatory system,I9_STR,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,1.01 [0.98-1.04],0.517386831956705,cis
Chapter IX Diseases of the circulatory system,I9_STR,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.02 [0.96-1.08],0.519399726459822,cis
Chapter IX Diseases of the circulatory system,I9_STR,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.92 [0.7-1.2],0.523504739048969,cis
Chapter IX Diseases of the circulatory system,I9_STR,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.02 [0.96-1.08],0.526093048014889,cis
Chapter IX Diseases of the circulatory system,I9_STR,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.03 [0.94-1.12],0.532639638003874,cis
Chapter IX Diseases of the circulatory system,I9_STR,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1.02 [0.97-1.07],0.535752628655103,cis
Chapter IX Diseases of the circulatory system,I9_STR,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.86 [0.53-1.39],0.53635849197155,cis
Chapter IX Diseases of the circulatory system,I9_STR,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,10,0.98 [0.92-1.04],0.538767335965678,cis
Chapter IX Diseases of the circulatory system,I9_STR,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.96 [0.83-1.1],0.539209372537807,cis
Chapter IX Diseases of the circulatory system,I9_STR,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.96 [0.82-1.11],0.55501157035554,cis
Chapter IX Diseases of the circulatory system,I9_STR,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.01 [0.97-1.06],0.558922704184395,cis
Chapter IX Diseases of the circulatory system,I9_STR,CTSL,Cathepsin L1,Wald ratio,1,0.88 [0.59-1.34],0.560246176326297,cis
Chapter IX Diseases of the circulatory system,I9_STR,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,0.99 [0.95-1.03],0.562729713456372,cis
Chapter IX Diseases of the circulatory system,I9_STR,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.01 [0.97-1.05],0.563159783125482,cis
Chapter IX Diseases of the circulatory system,I9_STR,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,0.9 [0.64-1.27],0.564252004472782,cis
Chapter IX Diseases of the circulatory system,I9_STR,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,0.96 [0.84-1.1],0.572215250172999,cis
Chapter IX Diseases of the circulatory system,I9_STR,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.93 [0.74-1.18],0.572544187415167,cis
Chapter IX Diseases of the circulatory system,I9_STR,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,0.99 [0.94-1.04],0.573334895602871,cis
Chapter IX Diseases of the circulatory system,I9_STR,CDH3,Cadherin-3,Inverse variance weighted,2,0.94 [0.75-1.17],0.590523726060355,cis
Chapter IX Diseases of the circulatory system,I9_STR,CD46,Membrane cofactor protein,Wald ratio,1,0.94 [0.76-1.17],0.593428824467261,cis
Chapter IX Diseases of the circulatory system,I9_STR,DPT,Dermatopontin,Inverse variance weighted,21,1.01 [0.96-1.07],0.603313410362388,cis
Chapter IX Diseases of the circulatory system,I9_STR,ANXA10,Annexin A10,Wald ratio,1,0.91 [0.62-1.32],0.605495752087203,cis
Chapter IX Diseases of the circulatory system,I9_STR,PRSS8,Prostasin,Inverse variance weighted,5,0.97 [0.84-1.1],0.607428689297663,cis
Chapter IX Diseases of the circulatory system,I9_STR,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,0.97 [0.86-1.09],0.608753143981775,cis
Chapter IX Diseases of the circulatory system,I9_STR,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.02 [0.95-1.08],0.611517909411598,cis
Chapter IX Diseases of the circulatory system,I9_STR,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.01 [0.96-1.06],0.614222214223507,cis
Chapter IX Diseases of the circulatory system,I9_STR,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,0.96 [0.83-1.12],0.615513337902578,cis
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.96 [0.8-1.14],0.626301480251228,cis
Chapter IX Diseases of the circulatory system,I9_STR,IL17C,Interleukin-17C,Inverse variance weighted,3,0.97 [0.84-1.11],0.638951749499143,cis
Chapter IX Diseases of the circulatory system,I9_STR,DSG2,Desmoglein-2,Inverse variance weighted,11,0.99 [0.93-1.05],0.640689020195857,cis
Chapter IX Diseases of the circulatory system,I9_STR,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.03 [0.92-1.15],0.643481666863286,cis
Chapter IX Diseases of the circulatory system,I9_STR,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,0.99 [0.93-1.05],0.645361059990167,cis
Chapter IX Diseases of the circulatory system,I9_STR,PSAP,Prosaposin,Inverse variance weighted,5,0.98 [0.9-1.07],0.64846518600865,cis
Chapter IX Diseases of the circulatory system,I9_STR,FOLR2,Folate receptor beta,Inverse variance weighted,2,0.96 [0.78-1.16],0.648530401769178,cis
Chapter IX Diseases of the circulatory system,I9_STR,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,1.01 [0.97-1.05],0.650403743271607,cis
Chapter IX Diseases of the circulatory system,I9_STR,RSPO3,R-spondin-3,Inverse variance weighted,6,1.04 [0.89-1.21],0.652346727124584,cis
Chapter IX Diseases of the circulatory system,I9_STR,CD27,CD27 antigen,Inverse variance weighted,9,1.01 [0.96-1.07],0.655675701597104,cis
Chapter IX Diseases of the circulatory system,I9_STR,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.05 [0.84-1.32],0.671334711356247,cis
Chapter IX Diseases of the circulatory system,I9_STR,PALM2,Paralemmin-2,Inverse variance weighted,8,0.98 [0.88-1.09],0.672370049041515,cis
Chapter IX Diseases of the circulatory system,I9_STR,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.01 [0.97-1.04],0.673370982314508,cis
Chapter IX Diseases of the circulatory system,I9_STR,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.99 [0.92-1.06],0.673959569327591,cis
Chapter IX Diseases of the circulatory system,I9_STR,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,0.99 [0.95-1.03],0.676708099626807,cis
Chapter IX Diseases of the circulatory system,I9_STR,NRP1,Neuropilin-1,Inverse variance weighted,12,0.99 [0.93-1.05],0.688848056083991,cis
Chapter IX Diseases of the circulatory system,I9_STR,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.99 [0.93-1.05],0.690235901413143,cis
Chapter IX Diseases of the circulatory system,I9_STR,LMNB2,Lamin-B2,Wald ratio,1,0.91 [0.57-1.45],0.692284900313345,cis
Chapter IX Diseases of the circulatory system,I9_STR,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.98 [0.87-1.1],0.710278362247415,cis
Chapter IX Diseases of the circulatory system,I9_STR,OMG,Oligodendrocyte-myelin glycoprotein,Wald ratio,1,0.95 [0.75-1.22],0.711032140194229,cis
Chapter IX Diseases of the circulatory system,I9_STR,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,0.99 [0.96-1.03],0.711675922813406,cis
Chapter IX Diseases of the circulatory system,I9_STR,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.98 [0.87-1.1],0.721700687832356,cis
Chapter IX Diseases of the circulatory system,I9_STR,NTF3,Neurotrophin-3,Inverse variance weighted,8,0.98 [0.87-1.1],0.721874969969586,cis
Chapter IX Diseases of the circulatory system,I9_STR,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.97 [0.81-1.16],0.722629495342993,cis
Chapter IX Diseases of the circulatory system,I9_STR,LGALS1,Galectin-1,Inverse variance weighted,6,0.99 [0.94-1.05],0.725587561193161,cis
Chapter IX Diseases of the circulatory system,I9_STR,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,0.99 [0.97-1.02],0.725971211155603,cis
Chapter IX Diseases of the circulatory system,I9_STR,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,0.99 [0.92-1.06],0.728279055015539,cis
Chapter IX Diseases of the circulatory system,I9_STR,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1.01 [0.97-1.04],0.729512773816946,cis
Chapter IX Diseases of the circulatory system,I9_STR,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.97 [0.83-1.14],0.732683093922966,cis
Chapter IX Diseases of the circulatory system,I9_STR,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,0.99 [0.93-1.05],0.733202309435066,cis
Chapter IX Diseases of the circulatory system,I9_STR,TFF1,Trefoil factor 1,Inverse variance weighted,8,1.01 [0.94-1.09],0.735880434854902,cis
Chapter IX Diseases of the circulatory system,I9_STR,SEPTIN8,Septin-8,Inverse variance weighted,2,1.03 [0.86-1.25],0.736056809567348,cis
Chapter IX Diseases of the circulatory system,I9_STR,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,0.99 [0.94-1.05],0.737453924240967,cis
Chapter IX Diseases of the circulatory system,I9_STR,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,0.99 [0.95-1.04],0.742958728606289,cis
Chapter IX Diseases of the circulatory system,I9_STR,ELN,Elastin,Inverse variance weighted,2,1.04 [0.81-1.34],0.763963022931153,cis
Chapter IX Diseases of the circulatory system,I9_STR,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,0.98 [0.89-1.09],0.766968227932584,cis
Chapter IX Diseases of the circulatory system,I9_STR,CD276,CD276 antigen,Inverse variance weighted,20,0.99 [0.95-1.04],0.769269982286696,cis
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,0.98 [0.87-1.11],0.770052836274491,cis
Chapter IX Diseases of the circulatory system,I9_STR,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,2,0.93 [0.58-1.5],0.773808354600372,cis
Chapter IX Diseases of the circulatory system,I9_STR,RETN,Resistin,Inverse variance weighted,9,0.99 [0.96-1.03],0.773871579727121,cis
Chapter IX Diseases of the circulatory system,I9_STR,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,0.99 [0.93-1.05],0.774070763578018,cis
Chapter IX Diseases of the circulatory system,I9_STR,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,1.02 [0.91-1.14],0.776279612027958,cis
Chapter IX Diseases of the circulatory system,I9_STR,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,0.97 [0.77-1.22],0.778697876619942,cis
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,1.07 [0.65-1.76],0.781668316614095,cis
Chapter IX Diseases of the circulatory system,I9_STR,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,0.98 [0.85-1.13],0.786854637988283,cis
Chapter IX Diseases of the circulatory system,I9_STR,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1 [0.97-1.02],0.789904353581629,cis
Chapter IX Diseases of the circulatory system,I9_STR,RNASET2,Ribonuclease T2,Inverse variance weighted,14,1.01 [0.96-1.06],0.794400920306042,cis
Chapter IX Diseases of the circulatory system,I9_STR,PRG2,Bone marrow proteoglycan,Wald ratio,1,1.03 [0.81-1.32],0.797342739944947,cis
Chapter IX Diseases of the circulatory system,I9_STR,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,1.02 [0.87-1.21],0.797894158310865,cis
Chapter IX Diseases of the circulatory system,I9_STR,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.01 [0.94-1.09],0.80437003385016,cis
Chapter IX Diseases of the circulatory system,I9_STR,MMP7,Matrilysin,Inverse variance weighted,13,1.01 [0.94-1.08],0.805416916497719,cis
Chapter IX Diseases of the circulatory system,I9_STR,OGN,Mimecan,Inverse variance weighted,30,1 [0.96-1.03],0.80845235557619,cis
Chapter IX Diseases of the circulatory system,I9_STR,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,1 [0.96-1.03],0.818709162618922,cis
Chapter IX Diseases of the circulatory system,I9_STR,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,0.99 [0.91-1.08],0.819558124697611,cis
Chapter IX Diseases of the circulatory system,I9_STR,CSTB,Cystatin-B,Inverse variance weighted,28,1 [0.97-1.04],0.822889491848353,cis
Chapter IX Diseases of the circulatory system,I9_STR,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,1.01 [0.93-1.1],0.824148817151884,cis
Chapter IX Diseases of the circulatory system,I9_STR,EFNA4,Ephrin-A4,Inverse variance weighted,3,1.02 [0.85-1.23],0.82464955545648,cis
Chapter IX Diseases of the circulatory system,I9_STR,FAM3C,Protein FAM3C,Inverse variance weighted,2,0.96 [0.7-1.34],0.825809551139739,cis
Chapter IX Diseases of the circulatory system,I9_STR,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,1.02 [0.86-1.22],0.828196425453326,cis
Chapter IX Diseases of the circulatory system,I9_STR,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,1.02 [0.84-1.23],0.844758804418218,cis
Chapter IX Diseases of the circulatory system,I9_STR,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,1 [0.96-1.05],0.848660801932739,cis
Chapter IX Diseases of the circulatory system,I9_STR,DSG3,Desmoglein-3,Inverse variance weighted,7,1.01 [0.94-1.08],0.862225941555062,cis
Chapter IX Diseases of the circulatory system,I9_STR,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,0.99 [0.86-1.13],0.866110249531301,cis
Chapter IX Diseases of the circulatory system,I9_STR,CALB1,Calbindin,Inverse variance weighted,2,1.02 [0.8-1.29],0.867108630610104,cis
Chapter IX Diseases of the circulatory system,I9_STR,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,0.99 [0.94-1.06],0.867563058063123,cis
Chapter IX Diseases of the circulatory system,I9_STR,IL19,Interleukin-19,Inverse variance weighted,11,1 [0.94-1.05],0.869824672136224,cis
Chapter IX Diseases of the circulatory system,I9_STR,AREG,Amphiregulin,Inverse variance weighted,3,1.01 [0.89-1.14],0.870432738203157,cis
Chapter IX Diseases of the circulatory system,I9_STR,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,0.99 [0.92-1.07],0.870779227992822,cis
Chapter IX Diseases of the circulatory system,I9_STR,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,0.99 [0.89-1.1],0.878911283041196,cis
Chapter IX Diseases of the circulatory system,I9_STR,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1 [0.95-1.06],0.885332801644691,cis
Chapter IX Diseases of the circulatory system,I9_STR,AGRN,Agrin,Inverse variance weighted,17,1 [0.95-1.06],0.888425965290842,cis
Chapter IX Diseases of the circulatory system,I9_STR,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.01 [0.92-1.11],0.893727614443968,cis
Chapter IX Diseases of the circulatory system,I9_STR,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.99 [0.84-1.17],0.91399428010423,cis
Chapter IX Diseases of the circulatory system,I9_STR,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,0.99 [0.8-1.22],0.928046284480485,cis
Chapter IX Diseases of the circulatory system,I9_STR,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1 [0.92-1.1],0.933012454400354,cis
Chapter IX Diseases of the circulatory system,I9_STR,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,21,1 [0.96-1.05],0.936133384712417,cis
Chapter IX Diseases of the circulatory system,I9_STR,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1.02 [0.66-1.58],0.936383205072672,cis
Chapter IX Diseases of the circulatory system,I9_STR,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,1.01 [0.71-1.44],0.94021514016004,cis
Chapter IX Diseases of the circulatory system,I9_STR,FBLN2,Fibulin-2,Inverse variance weighted,11,1 [0.95-1.05],0.951277974683057,cis
Chapter IX Diseases of the circulatory system,I9_STR,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,1.01 [0.79-1.29],0.95287465931922,cis
Chapter IX Diseases of the circulatory system,I9_STR,BGLAP,Osteocalcin,Inverse variance weighted,2,1.01 [0.69-1.49],0.953711138873642,cis
Chapter IX Diseases of the circulatory system,I9_STR,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.99 [0.82-1.2],0.955208311511008,cis
Chapter IX Diseases of the circulatory system,I9_STR,MATN2,Matrilin-2,Inverse variance weighted,18,1 [0.94-1.06],0.957645047261612,cis
Chapter IX Diseases of the circulatory system,I9_STR,GFAP,Glial fibrillary acidic protein,Inverse variance weighted,4,1 [0.85-1.19],0.958839900364602,cis
Chapter IX Diseases of the circulatory system,I9_STR,NRP2,Neuropilin-2,Inverse variance weighted,11,1 [0.94-1.07],0.961886435462452,cis
Chapter IX Diseases of the circulatory system,I9_STR,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,1 [0.89-1.12],0.962846610999617,cis
Chapter IX Diseases of the circulatory system,I9_STR,NID2,Nidogen-2,Inverse variance weighted,33,1 [0.97-1.03],0.969941533238535,cis
Chapter IX Diseases of the circulatory system,I9_STR,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1 [0.96-1.04],0.975592190576813,cis
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,1 [0.91-1.1],0.978437354696882,cis
Chapter IX Diseases of the circulatory system,I9_STR,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1 [0.94-1.07],0.978930316306625,cis
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,1 [0.96-1.04],0.98379308370316,cis
Chapter IX Diseases of the circulatory system,I9_STR,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1 [0.98-1.03],0.98496481854237,cis
Chapter IX Diseases of the circulatory system,I9_STR,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,1 [0.94-1.06],0.986212797979874,cis
Chapter IX Diseases of the circulatory system,I9_STR,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,1 [0.7-1.42],0.991963016952932,cis
Chapter IX Diseases of the circulatory system,I9_STR,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,1 [0.89-1.12],0.994104652952448,cis
Chapter IX Diseases of the circulatory system,I9_STR,DLL1,Delta-like protein 1,Inverse variance weighted,7,1 [0.91-1.1],0.994480205367828,cis
Chapter IX Diseases of the circulatory system,I9_STR,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,1 [0.94-1.06],0.995064606952033,cis
Chapter IX Diseases of the circulatory system,I9_STR,CFD,Complement factor D,Inverse variance weighted,11,1 [0.94-1.06],0.997474470927162,cis
Chapter IX Diseases of the circulatory system,I9_STR,REN,Renin,Inverse variance weighted,8,0.69 [0.56-0.86],0.00110382716983453,trans
Chapter IX Diseases of the circulatory system,I9_STR,PI3,Elafin,Inverse variance weighted,18,1.09 [1.03-1.14],0.00212926701944974,trans
Chapter IX Diseases of the circulatory system,I9_STR,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.1 [1.03-1.17],0.00262600779834049,trans
Chapter IX Diseases of the circulatory system,I9_STR,PGF,Placenta growth factor,Inverse variance weighted,5,0.78 [0.66-0.92],0.00404613472823174,trans
Chapter IX Diseases of the circulatory system,I9_STR,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.91 [0.85-0.97],0.00529188601841326,trans
Chapter IX Diseases of the circulatory system,I9_STR,MDK,Midkine,Inverse variance weighted,14,1.16 [1.03-1.31],0.0121017499049339,trans
Chapter IX Diseases of the circulatory system,I9_STR,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.34 [1.06-1.69],0.0126679937993892,trans
Chapter IX Diseases of the circulatory system,I9_STR,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,1.3 [1.04-1.63],0.0207402189753114,trans
Chapter IX Diseases of the circulatory system,I9_STR,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.2 [1.03-1.4],0.0218618218388861,trans
Chapter IX Diseases of the circulatory system,I9_STR,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,11,1.18 [1.02-1.36],0.0220464911578544,trans
Chapter IX Diseases of the circulatory system,I9_STR,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,1.21 [1.02-1.42],0.0275493213632443,trans
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,1.19 [1.02-1.4],0.0307380447991986,trans
Chapter IX Diseases of the circulatory system,I9_STR,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.32 [1.03-1.7],0.0307775375132012,trans
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.35 [1.03-1.77],0.0310737586653452,trans
Chapter IX Diseases of the circulatory system,I9_STR,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,1.34 [1.03-1.76],0.0312822469613741,trans
Chapter IX Diseases of the circulatory system,I9_STR,DSC2,Desmocollin-2,Inverse variance weighted,16,0.94 [0.89-1],0.0364038701417275,trans
Chapter IX Diseases of the circulatory system,I9_STR,APOC1,Apolipoprotein C-I,Inverse variance weighted,12,0.91 [0.83-1],0.0391175810049294,trans
Chapter IX Diseases of the circulatory system,I9_STR,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,1.21 [1.01-1.46],0.0431688664456164,trans
Chapter IX Diseases of the circulatory system,I9_STR,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.33 [1.01-1.76],0.0455002102872922,trans
Chapter IX Diseases of the circulatory system,I9_STR,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,0.82 [0.67-1],0.0462122561747908,trans
Chapter IX Diseases of the circulatory system,I9_STR,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,1.07 [1-1.14],0.0505627967638358,trans
Chapter IX Diseases of the circulatory system,I9_STR,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.1 [1-1.21],0.0559072067988183,trans
Chapter IX Diseases of the circulatory system,I9_STR,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.25 [0.99-1.57],0.0566302427753454,trans
Chapter IX Diseases of the circulatory system,I9_STR,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,0.85 [0.71-1.01],0.0605990261062067,trans
Chapter IX Diseases of the circulatory system,I9_STR,MMP7,Matrilysin,Wald ratio,1,1.18 [0.99-1.4],0.0672577335288126,trans
Chapter IX Diseases of the circulatory system,I9_STR,F10,Coagulation factor X,Inverse variance weighted,11,0.89 [0.78-1.01],0.0706582894006841,trans
Chapter IX Diseases of the circulatory system,I9_STR,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,11,0.96 [0.92-1],0.0719583745754818,trans
Chapter IX Diseases of the circulatory system,I9_STR,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,1.2 [0.98-1.46],0.0743958869623123,trans
Chapter IX Diseases of the circulatory system,I9_STR,CTSL,Cathepsin L1,Inverse variance weighted,29,0.94 [0.88-1.01],0.0752176544148606,trans
Chapter IX Diseases of the circulatory system,I9_STR,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.09 [0.99-1.2],0.0769175918680531,trans
Chapter IX Diseases of the circulatory system,I9_STR,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.92 [0.84-1.01],0.0790117516041282,trans
Chapter IX Diseases of the circulatory system,I9_STR,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.34 [0.96-1.85],0.0834529353314827,trans
Chapter IX Diseases of the circulatory system,I9_STR,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,0.83 [0.67-1.03],0.087226452437344,trans
Chapter IX Diseases of the circulatory system,I9_STR,THBS2,Thrombospondin-2,Inverse variance weighted,15,1.07 [0.99-1.15],0.0898229215725838,trans
Chapter IX Diseases of the circulatory system,I9_STR,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,0.97 [0.93-1.01],0.0913119115521312,trans
Chapter IX Diseases of the circulatory system,I9_STR,IL6,Interleukin-6,Inverse variance weighted,6,0.93 [0.86-1.01],0.0913843896676596,trans
Chapter IX Diseases of the circulatory system,I9_STR,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.31 [0.96-1.79],0.0918894563500111,trans
Chapter IX Diseases of the circulatory system,I9_STR,NRP1,Neuropilin-1,Inverse variance weighted,14,1.14 [0.98-1.33],0.0959058823865987,trans
Chapter IX Diseases of the circulatory system,I9_STR,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,0.98 [0.95-1],0.104363523266567,trans
Chapter IX Diseases of the circulatory system,I9_STR,ITGAV,Integrin alpha-V,Inverse variance weighted,10,0.9 [0.79-1.02],0.105991058743872,trans
Chapter IX Diseases of the circulatory system,I9_STR,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,1.08 [0.98-1.18],0.106109584790343,trans
Chapter IX Diseases of the circulatory system,I9_STR,LEP,Leptin,Inverse variance weighted,4,1.24 [0.95-1.62],0.113204653075478,trans
Chapter IX Diseases of the circulatory system,I9_STR,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.15 [0.96-1.36],0.120299611593693,trans
Chapter IX Diseases of the circulatory system,I9_STR,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.18 [0.95-1.46],0.126994247663755,trans
Chapter IX Diseases of the circulatory system,I9_STR,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,0.92 [0.83-1.02],0.127311848020833,trans
Chapter IX Diseases of the circulatory system,I9_STR,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.09 [0.98-1.21],0.127391177685471,trans
Chapter IX Diseases of the circulatory system,I9_STR,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.91 [0.81-1.03],0.13712135871274,trans
Chapter IX Diseases of the circulatory system,I9_STR,ITGA11,Integrin alpha-11,Inverse variance weighted,7,0.9 [0.79-1.03],0.137398617010482,trans
Chapter IX Diseases of the circulatory system,I9_STR,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.07 [0.98-1.18],0.138048316066591,trans
Chapter IX Diseases of the circulatory system,I9_STR,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,0.96 [0.91-1.01],0.139330185143875,trans
Chapter IX Diseases of the circulatory system,I9_STR,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1.03 [0.99-1.07],0.139853137832078,trans
Chapter IX Diseases of the circulatory system,I9_STR,LGALS9,Galectin-9,Inverse variance weighted,36,1.03 [0.99-1.07],0.147955422234486,trans
Chapter IX Diseases of the circulatory system,I9_STR,NECTIN2,Nectin-2,Inverse variance weighted,3,1.25 [0.92-1.7],0.15200198118513,trans
Chapter IX Diseases of the circulatory system,I9_STR,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,0.81 [0.6-1.09],0.155300489189892,trans
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.11 [0.96-1.29],0.156815740276727,trans
Chapter IX Diseases of the circulatory system,I9_STR,SPON1,Spondin-1,Inverse variance weighted,4,0.87 [0.71-1.06],0.157095021499642,trans
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,1.19 [0.94-1.5],0.15724483117425,trans
Chapter IX Diseases of the circulatory system,I9_STR,CD276,CD276 antigen,Inverse variance weighted,24,0.95 [0.87-1.02],0.158878922941864,trans
Chapter IX Diseases of the circulatory system,I9_STR,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.06 [0.98-1.14],0.163905924665975,trans
Chapter IX Diseases of the circulatory system,I9_STR,FOLR2,Folate receptor beta,Inverse variance weighted,14,0.94 [0.86-1.03],0.167196457848867,trans
Chapter IX Diseases of the circulatory system,I9_STR,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,0.91 [0.8-1.04],0.17093003801424,trans
Chapter IX Diseases of the circulatory system,I9_STR,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.06 [0.98-1.15],0.171810379229018,trans
Chapter IX Diseases of the circulatory system,I9_STR,NID1,Nidogen-1,Inverse variance weighted,6,0.9 [0.77-1.05],0.17443421135585,trans
Chapter IX Diseases of the circulatory system,I9_STR,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,0.96 [0.91-1.02],0.178393988882597,trans
Chapter IX Diseases of the circulatory system,I9_STR,BSG,Basigin,Inverse variance weighted,6,1.2 [0.92-1.57],0.178895865401435,trans
Chapter IX Diseases of the circulatory system,I9_STR,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,0.92 [0.81-1.04],0.186430465010435,trans
Chapter IX Diseases of the circulatory system,I9_STR,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,1.08 [0.96-1.22],0.191306067233534,trans
Chapter IX Diseases of the circulatory system,I9_STR,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.11 [0.95-1.3],0.194760342703489,trans
Chapter IX Diseases of the circulatory system,I9_STR,WNT9A,Protein Wnt-9a,Wald ratio,1,1.42 [0.83-2.43],0.19718288868699,trans
Chapter IX Diseases of the circulatory system,I9_STR,CD27,CD27 antigen,Inverse variance weighted,9,1.13 [0.94-1.37],0.201655223923739,trans
Chapter IX Diseases of the circulatory system,I9_STR,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,1.08 [0.96-1.21],0.202208452989106,trans
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,1.1 [0.95-1.28],0.211313570019725,trans
Chapter IX Diseases of the circulatory system,I9_STR,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,0.98 [0.95-1.01],0.213694814110784,trans
Chapter IX Diseases of the circulatory system,I9_STR,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,0.93 [0.83-1.04],0.216223600244258,trans
Chapter IX Diseases of the circulatory system,I9_STR,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,1.1 [0.94-1.28],0.220738645448676,trans
Chapter IX Diseases of the circulatory system,I9_STR,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,27,1.04 [0.98-1.1],0.220758224815165,trans
Chapter IX Diseases of the circulatory system,I9_STR,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,1.09 [0.95-1.26],0.229771827074941,trans
Chapter IX Diseases of the circulatory system,I9_STR,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,1.15 [0.91-1.46],0.230245741594866,trans
Chapter IX Diseases of the circulatory system,I9_STR,LGALS4,Galectin-4,Inverse variance weighted,15,0.97 [0.92-1.02],0.230725965604568,trans
Chapter IX Diseases of the circulatory system,I9_STR,C7,Complement component C7,Inverse variance weighted,26,1.03 [0.98-1.09],0.231366396995907,trans
Chapter IX Diseases of the circulatory system,I9_STR,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.25 [0.86-1.81],0.234476933595309,trans
Chapter IX Diseases of the circulatory system,I9_STR,CALB1,Calbindin,Inverse variance weighted,9,1.08 [0.95-1.22],0.236437301465978,trans
Chapter IX Diseases of the circulatory system,I9_STR,CA4,Carbonic anhydrase 4,Inverse variance weighted,25,1.03 [0.98-1.07],0.237555175985624,trans
Chapter IX Diseases of the circulatory system,I9_STR,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.12 [0.93-1.36],0.238870686367577,trans
Chapter IX Diseases of the circulatory system,I9_STR,AMBP,Protein AMBP,Inverse variance weighted,5,1.09 [0.95-1.25],0.241923916214779,trans
Chapter IX Diseases of the circulatory system,I9_STR,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,14,0.95 [0.86-1.04],0.258855434978273,trans
Chapter IX Diseases of the circulatory system,I9_STR,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,0.94 [0.85-1.05],0.261874334474471,trans
Chapter IX Diseases of the circulatory system,I9_STR,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.92 [0.79-1.07],0.264588358454033,trans
Chapter IX Diseases of the circulatory system,I9_STR,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,0.84 [0.61-1.15],0.275854230024331,trans
Chapter IX Diseases of the circulatory system,I9_STR,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.29 [0.81-2.06],0.278228943393702,trans
Chapter IX Diseases of the circulatory system,I9_STR,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,18,1.06 [0.96-1.16],0.282967134598413,trans
Chapter IX Diseases of the circulatory system,I9_STR,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.91 [0.78-1.08],0.285919562017325,trans
Chapter IX Diseases of the circulatory system,I9_STR,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,0.9 [0.73-1.1],0.29419885910999,trans
Chapter IX Diseases of the circulatory system,I9_STR,UMOD,Uromodulin,Inverse variance weighted,34,0.97 [0.9-1.03],0.295153622864661,trans
Chapter IX Diseases of the circulatory system,I9_STR,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.11 [0.91-1.36],0.300134441733673,trans
Chapter IX Diseases of the circulatory system,I9_STR,OMG,Oligodendrocyte-myelin glycoprotein,Inverse variance weighted,15,0.95 [0.87-1.05],0.313501108265891,trans
Chapter IX Diseases of the circulatory system,I9_STR,NRP2,Neuropilin-2,Inverse variance weighted,14,1.09 [0.92-1.29],0.314443185530559,trans
Chapter IX Diseases of the circulatory system,I9_STR,CCN3,CCN family member 3,Inverse variance weighted,17,1.04 [0.96-1.12],0.315301921371407,trans
Chapter IX Diseases of the circulatory system,I9_STR,CCN5,CCN family member 5,Inverse variance weighted,12,0.97 [0.91-1.03],0.315831624830511,trans
Chapter IX Diseases of the circulatory system,I9_STR,DKK3,Dickkopf-related protein 3,Inverse variance weighted,14,1.03 [0.97-1.11],0.316067934674607,trans
Chapter IX Diseases of the circulatory system,I9_STR,IL15,Interleukin-15,Inverse variance weighted,35,1.03 [0.97-1.09],0.317752617784508,trans
Chapter IX Diseases of the circulatory system,I9_STR,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,0.93 [0.81-1.07],0.320045396177393,trans
Chapter IX Diseases of the circulatory system,I9_STR,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,0.98 [0.93-1.02],0.321095774280987,trans
Chapter IX Diseases of the circulatory system,I9_STR,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,1.04 [0.96-1.12],0.322577129859517,trans
Chapter IX Diseases of the circulatory system,I9_STR,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,0.97 [0.92-1.03],0.324599129079082,trans
Chapter IX Diseases of the circulatory system,I9_STR,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,0.92 [0.79-1.08],0.32958270397506,trans
Chapter IX Diseases of the circulatory system,I9_STR,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.04 [0.96-1.11],0.329714275319289,trans
Chapter IX Diseases of the circulatory system,I9_STR,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,1.1 [0.91-1.34],0.331002110315196,trans
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.89 [0.71-1.12],0.333381251256413,trans
Chapter IX Diseases of the circulatory system,I9_STR,SIAE,Sialate O-acetylesterase,Inverse variance weighted,6,0.92 [0.79-1.08],0.333916706720368,trans
Chapter IX Diseases of the circulatory system,I9_STR,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,0.9 [0.73-1.11],0.334113852995303,trans
Chapter IX Diseases of the circulatory system,I9_STR,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.07 [0.94-1.21],0.335484934522189,trans
Chapter IX Diseases of the circulatory system,I9_STR,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1.03 [0.97-1.1],0.341473119442555,trans
Chapter IX Diseases of the circulatory system,I9_STR,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,1.08 [0.92-1.27],0.34207785714221,trans
Chapter IX Diseases of the circulatory system,I9_STR,APCS,Serum amyloid P-component,Inverse variance weighted,3,0.89 [0.71-1.13],0.355129279773818,trans
Chapter IX Diseases of the circulatory system,I9_STR,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.02 [0.98-1.06],0.356910098841208,trans
Chapter IX Diseases of the circulatory system,I9_STR,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1.04 [0.95-1.14],0.357147948225474,trans
Chapter IX Diseases of the circulatory system,I9_STR,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,1.08 [0.92-1.26],0.362026564032123,trans
Chapter IX Diseases of the circulatory system,I9_STR,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.08 [0.92-1.26],0.362069771709373,trans
Chapter IX Diseases of the circulatory system,I9_STR,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,0.92 [0.77-1.1],0.363371562362073,trans
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,1.04 [0.95-1.14],0.367941678972947,trans
Chapter IX Diseases of the circulatory system,I9_STR,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.13 [0.86-1.5],0.380512116552898,trans
Chapter IX Diseases of the circulatory system,I9_STR,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,19,1.05 [0.94-1.19],0.380812393241862,trans
Chapter IX Diseases of the circulatory system,I9_STR,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,1.07 [0.92-1.25],0.382847109828398,trans
Chapter IX Diseases of the circulatory system,I9_STR,PSAP,Prosaposin,Inverse variance weighted,13,0.97 [0.91-1.04],0.384383639022522,trans
Chapter IX Diseases of the circulatory system,I9_STR,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.83 [0.54-1.27],0.384528879724281,trans
Chapter IX Diseases of the circulatory system,I9_STR,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,0.94 [0.82-1.08],0.385614436856887,trans
Chapter IX Diseases of the circulatory system,I9_STR,PALM,Paralemmin-1,Inverse variance weighted,4,0.92 [0.77-1.11],0.386980498465314,trans
Chapter IX Diseases of the circulatory system,I9_STR,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1.02 [0.98-1.06],0.390041287547044,trans
Chapter IX Diseases of the circulatory system,I9_STR,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.09 [0.89-1.34],0.392831250423955,trans
Chapter IX Diseases of the circulatory system,I9_STR,SEPTIN8,Septin-8,Inverse variance weighted,4,0.89 [0.69-1.16],0.394596973726732,trans
Chapter IX Diseases of the circulatory system,I9_STR,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.07 [0.92-1.24],0.400157764662791,trans
Chapter IX Diseases of the circulatory system,I9_STR,CHGA,Chromogranin-A,Inverse variance weighted,5,0.94 [0.82-1.08],0.404434770514048,trans
Chapter IX Diseases of the circulatory system,I9_STR,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,1.28 [0.71-2.29],0.408750298563491,trans
Chapter IX Diseases of the circulatory system,I9_STR,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.1 [0.87-1.4],0.409680695981276,trans
Chapter IX Diseases of the circulatory system,I9_STR,LGALS3,Galectin-3,Inverse variance weighted,15,1.04 [0.95-1.13],0.416743225788319,trans
Chapter IX Diseases of the circulatory system,I9_STR,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.91 [0.72-1.14],0.420017801221543,trans
Chapter IX Diseases of the circulatory system,I9_STR,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,1.04 [0.94-1.15],0.420275116917757,trans
Chapter IX Diseases of the circulatory system,I9_STR,BGLAP,Osteocalcin,Inverse variance weighted,8,0.94 [0.8-1.1],0.420685718788507,trans
Chapter IX Diseases of the circulatory system,I9_STR,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,0.96 [0.88-1.06],0.422601262994708,trans
Chapter IX Diseases of the circulatory system,I9_STR,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.12 [0.84-1.5],0.423685351897869,trans
Chapter IX Diseases of the circulatory system,I9_STR,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,0.92 [0.75-1.13],0.424023640858475,trans
Chapter IX Diseases of the circulatory system,I9_STR,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,0.87 [0.62-1.22],0.425274858234912,trans
Chapter IX Diseases of the circulatory system,I9_STR,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.97 [0.88-1.05],0.430589546989247,trans
Chapter IX Diseases of the circulatory system,I9_STR,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,1.06 [0.92-1.22],0.443393184893456,trans
Chapter IX Diseases of the circulatory system,I9_STR,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.96 [0.87-1.06],0.449854947504406,trans
Chapter IX Diseases of the circulatory system,I9_STR,GFAP,Glial fibrillary acidic protein,Inverse variance weighted,14,0.96 [0.87-1.07],0.450479929839976,trans
Chapter IX Diseases of the circulatory system,I9_STR,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,1.03 [0.96-1.1],0.451916789476579,trans
Chapter IX Diseases of the circulatory system,I9_STR,GRN,Progranulin,Inverse variance weighted,46,1.01 [0.98-1.05],0.459941417593068,trans
Chapter IX Diseases of the circulatory system,I9_STR,NTF3,Neurotrophin-3,Inverse variance weighted,11,1.05 [0.92-1.19],0.460830378738869,trans
Chapter IX Diseases of the circulatory system,I9_STR,DSG2,Desmoglein-2,Inverse variance weighted,22,0.98 [0.92-1.04],0.466435977938444,trans
Chapter IX Diseases of the circulatory system,I9_STR,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.04 [0.94-1.14],0.466954355347204,trans
Chapter IX Diseases of the circulatory system,I9_STR,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,1.03 [0.95-1.11],0.467570429696048,trans
Chapter IX Diseases of the circulatory system,I9_STR,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.08 [0.88-1.33],0.471457008970463,trans
Chapter IX Diseases of the circulatory system,I9_STR,XG,Glycoprotein Xg,Inverse variance weighted,2,0.89 [0.65-1.23],0.477513209718733,trans
Chapter IX Diseases of the circulatory system,I9_STR,CFC1,Cryptic protein,Inverse variance weighted,11,0.96 [0.84-1.08],0.477726684001375,trans
Chapter IX Diseases of the circulatory system,I9_STR,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.94 [0.8-1.11],0.480888342307809,trans
Chapter IX Diseases of the circulatory system,I9_STR,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,0.95 [0.83-1.09],0.480903274517022,trans
Chapter IX Diseases of the circulatory system,I9_STR,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.01 [0.98-1.03],0.48744516166083,trans
Chapter IX Diseases of the circulatory system,I9_STR,CD302,CD302 antigen,Inverse variance weighted,11,0.96 [0.86-1.08],0.487606609308955,trans
Chapter IX Diseases of the circulatory system,I9_STR,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,0.97 [0.9-1.05],0.48930822893492,trans
Chapter IX Diseases of the circulatory system,I9_STR,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,1.01 [0.98-1.04],0.50078668131974,trans
Chapter IX Diseases of the circulatory system,I9_STR,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,1.04 [0.93-1.17],0.502212671883578,trans
Chapter IX Diseases of the circulatory system,I9_STR,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,1.06 [0.9-1.24],0.505280917346421,trans
Chapter IX Diseases of the circulatory system,I9_STR,BCAN,Brevican core protein,Inverse variance weighted,12,1.05 [0.91-1.21],0.510218885123003,trans
Chapter IX Diseases of the circulatory system,I9_STR,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.06 [0.89-1.25],0.515313278687525,trans
Chapter IX Diseases of the circulatory system,I9_STR,MATN2,Matrilin-2,Inverse variance weighted,28,1.01 [0.98-1.05],0.520558696650239,trans
Chapter IX Diseases of the circulatory system,I9_STR,CD93,Complement component C1q receptor,Inverse variance weighted,2,0.92 [0.71-1.19],0.522801252001494,trans
Chapter IX Diseases of the circulatory system,I9_STR,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,0.94 [0.78-1.14],0.523171091286746,trans
Chapter IX Diseases of the circulatory system,I9_STR,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,1.05 [0.89-1.24],0.529008880607899,trans
Chapter IX Diseases of the circulatory system,I9_STR,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,0.86 [0.54-1.38],0.531597079501766,trans
Chapter IX Diseases of the circulatory system,I9_STR,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.1 [0.81-1.5],0.53708521166019,trans
Chapter IX Diseases of the circulatory system,I9_STR,OCLN,Occludin,Inverse variance weighted,2,0.92 [0.7-1.2],0.540203611289548,trans
Chapter IX Diseases of the circulatory system,I9_STR,COLEC12,Collectin-12,Inverse variance weighted,3,1.22 [0.64-2.32],0.543446052839261,trans
Chapter IX Diseases of the circulatory system,I9_STR,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,1.02 [0.96-1.08],0.543922414334562,trans
Chapter IX Diseases of the circulatory system,I9_STR,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,0.99 [0.96-1.02],0.54408868118643,trans
Chapter IX Diseases of the circulatory system,I9_STR,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.05 [0.9-1.23],0.544506356260569,trans
Chapter IX Diseases of the circulatory system,I9_STR,SHISA5,Protein shisa-5,Inverse variance weighted,12,0.96 [0.83-1.1],0.546007626704583,trans
Chapter IX Diseases of the circulatory system,I9_STR,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.97 [0.88-1.07],0.553675548444447,trans
Chapter IX Diseases of the circulatory system,I9_STR,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,1.02 [0.95-1.11],0.558949418621021,trans
Chapter IX Diseases of the circulatory system,I9_STR,FBLN2,Fibulin-2,Inverse variance weighted,6,0.96 [0.83-1.11],0.559156055685265,trans
Chapter IX Diseases of the circulatory system,I9_STR,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.83 [0.45-1.54],0.559206889269099,trans
Chapter IX Diseases of the circulatory system,I9_STR,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,1.03 [0.93-1.14],0.561580807588171,trans
Chapter IX Diseases of the circulatory system,I9_STR,CKB,Creatine kinase B-type,Inverse variance weighted,11,1.04 [0.92-1.17],0.569352817288202,trans
Chapter IX Diseases of the circulatory system,I9_STR,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1.18 [0.66-2.12],0.573028861296566,trans
Chapter IX Diseases of the circulatory system,I9_STR,ANG,Angiogenin,Inverse variance weighted,8,0.93 [0.72-1.2],0.573111649054202,trans
Chapter IX Diseases of the circulatory system,I9_STR,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1.14 [0.71-1.85],0.581952352634939,trans
Chapter IX Diseases of the circulatory system,I9_STR,AGRN,Agrin,Inverse variance weighted,14,0.96 [0.85-1.1],0.583366170200002,trans
Chapter IX Diseases of the circulatory system,I9_STR,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,1.01 [0.97-1.05],0.586141692772833,trans
Chapter IX Diseases of the circulatory system,I9_STR,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,20,1.02 [0.95-1.1],0.587182556421458,trans
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,0.98 [0.9-1.06],0.591665148899611,trans
Chapter IX Diseases of the circulatory system,I9_STR,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.98 [0.9-1.06],0.592967911990885,trans
Chapter IX Diseases of the circulatory system,I9_STR,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,14,0.98 [0.89-1.07],0.598759253460102,trans
Chapter IX Diseases of the circulatory system,I9_STR,CSTB,Cystatin-B,Inverse variance weighted,23,1.01 [0.97-1.05],0.601059752678425,trans
Chapter IX Diseases of the circulatory system,I9_STR,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,0.94 [0.75-1.18],0.603521974244333,trans
Chapter IX Diseases of the circulatory system,I9_STR,IL17C,Interleukin-17C,Inverse variance weighted,5,1.08 [0.81-1.43],0.605716117518042,trans
Chapter IX Diseases of the circulatory system,I9_STR,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,1.09 [0.78-1.55],0.608229678861142,trans
Chapter IX Diseases of the circulatory system,I9_STR,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,1.01 [0.97-1.06],0.610332058921814,trans
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.99 [0.95-1.03],0.614726804273661,trans
Chapter IX Diseases of the circulatory system,I9_STR,KLK4,Kallikrein-4,Inverse variance weighted,5,0.92 [0.67-1.27],0.615317446411643,trans
Chapter IX Diseases of the circulatory system,I9_STR,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.92 [0.66-1.28],0.617591215546001,trans
Chapter IX Diseases of the circulatory system,I9_STR,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,0.99 [0.95-1.03],0.62263613980406,trans
Chapter IX Diseases of the circulatory system,I9_STR,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,1.09 [0.77-1.54],0.624989514268596,trans
Chapter IX Diseases of the circulatory system,I9_STR,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.95 [0.79-1.15],0.627008956321282,trans
Chapter IX Diseases of the circulatory system,I9_STR,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.03 [0.91-1.17],0.630646733867806,trans
Chapter IX Diseases of the circulatory system,I9_STR,RNASET2,Ribonuclease T2,Inverse variance weighted,10,0.97 [0.86-1.09],0.634975356835462,trans
Chapter IX Diseases of the circulatory system,I9_STR,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.02 [0.94-1.11],0.637447306527475,trans
Chapter IX Diseases of the circulatory system,I9_STR,PALM2,Paralemmin-2,Inverse variance weighted,9,0.98 [0.89-1.08],0.639689070709867,trans
Chapter IX Diseases of the circulatory system,I9_STR,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,1.05 [0.86-1.27],0.639723583412697,trans
Chapter IX Diseases of the circulatory system,I9_STR,TNC,Tenascin,Inverse variance weighted,57,1.01 [0.97-1.04],0.640286548257809,trans
Chapter IX Diseases of the circulatory system,I9_STR,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,0.98 [0.89-1.08],0.641722357242729,trans
Chapter IX Diseases of the circulatory system,I9_STR,NID2,Nidogen-2,Inverse variance weighted,8,1.05 [0.84-1.32],0.641750202836058,trans
Chapter IX Diseases of the circulatory system,I9_STR,RETN,Resistin,Inverse variance weighted,19,0.98 [0.88-1.08],0.641793392633737,trans
Chapter IX Diseases of the circulatory system,I9_STR,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.98 [0.89-1.08],0.643136016253964,trans
Chapter IX Diseases of the circulatory system,I9_STR,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.01 [0.95-1.08],0.646372662950267,trans
Chapter IX Diseases of the circulatory system,I9_STR,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1.01 [0.95-1.08],0.649399123837272,trans
Chapter IX Diseases of the circulatory system,I9_STR,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,1.05 [0.84-1.33],0.65236479458566,trans
Chapter IX Diseases of the circulatory system,I9_STR,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,0.95 [0.75-1.2],0.660874194555839,trans
Chapter IX Diseases of the circulatory system,I9_STR,IL19,Interleukin-19,Inverse variance weighted,10,1.02 [0.95-1.09],0.662948217605969,trans
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.96 [0.79-1.17],0.665193147464087,trans
Chapter IX Diseases of the circulatory system,I9_STR,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,0.98 [0.91-1.06],0.671271810703552,trans
Chapter IX Diseases of the circulatory system,I9_STR,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,0.97 [0.85-1.11],0.685588029167044,trans
Chapter IX Diseases of the circulatory system,I9_STR,DSG3,Desmoglein-3,Inverse variance weighted,27,0.99 [0.94-1.04],0.688442570593811,trans
Chapter IX Diseases of the circulatory system,I9_STR,KLK11,Kallikrein-11,Inverse variance weighted,13,1.02 [0.93-1.12],0.69819410226309,trans
Chapter IX Diseases of the circulatory system,I9_STR,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.95 [0.74-1.22],0.701268278950272,trans
Chapter IX Diseases of the circulatory system,I9_STR,PRSS8,Prostasin,Inverse variance weighted,14,0.98 [0.87-1.1],0.701625303094361,trans
Chapter IX Diseases of the circulatory system,I9_STR,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.96 [0.8-1.17],0.703232232575026,trans
Chapter IX Diseases of the circulatory system,I9_STR,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.04 [0.84-1.29],0.703328806244173,trans
Chapter IX Diseases of the circulatory system,I9_STR,RSPO3,R-spondin-3,Inverse variance weighted,5,0.95 [0.74-1.22],0.706426510137791,trans
Chapter IX Diseases of the circulatory system,I9_STR,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,0.99 [0.96-1.03],0.707966234650792,trans
Chapter IX Diseases of the circulatory system,I9_STR,EFNA1,Ephrin-A1,Inverse variance weighted,3,0.95 [0.72-1.25],0.710965189043261,trans
Chapter IX Diseases of the circulatory system,I9_STR,CD83,CD83 antigen,Inverse variance weighted,14,0.98 [0.86-1.11],0.726674147170021,trans
Chapter IX Diseases of the circulatory system,I9_STR,AREG,Amphiregulin,Inverse variance weighted,5,0.97 [0.81-1.16],0.729379617019555,trans
Chapter IX Diseases of the circulatory system,I9_STR,ELN,Elastin,Inverse variance weighted,10,0.96 [0.77-1.21],0.729433434817721,trans
Chapter IX Diseases of the circulatory system,I9_STR,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.92 [0.59-1.45],0.731126477560668,trans
Chapter IX Diseases of the circulatory system,I9_STR,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,0.97 [0.83-1.14],0.731833321881265,trans
Chapter IX Diseases of the circulatory system,I9_STR,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,11,1.02 [0.92-1.12],0.742097688227358,trans
Chapter IX Diseases of the circulatory system,I9_STR,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.98 [0.87-1.11],0.758052159649242,trans
Chapter IX Diseases of the circulatory system,I9_STR,RNASE6,Ribonuclease K6,Inverse variance weighted,4,0.96 [0.75-1.23],0.761329369792655,trans
Chapter IX Diseases of the circulatory system,I9_STR,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,1.04 [0.83-1.29],0.762232482495031,trans
Chapter IX Diseases of the circulatory system,I9_STR,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,19,0.99 [0.92-1.06],0.76901615796875,trans
Chapter IX Diseases of the circulatory system,I9_STR,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.96 [0.76-1.23],0.769902718613808,trans
Chapter IX Diseases of the circulatory system,I9_STR,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.05 [0.77-1.41],0.77219641778005,trans
Chapter IX Diseases of the circulatory system,I9_STR,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,1.04 [0.8-1.35],0.772926456837645,trans
Chapter IX Diseases of the circulatory system,I9_STR,CFD,Complement factor D,Wald ratio,1,0.94 [0.63-1.41],0.779582402116474,trans
Chapter IX Diseases of the circulatory system,I9_STR,CDH3,Cadherin-3,Inverse variance weighted,10,1.02 [0.91-1.14],0.78319175849838,trans
Chapter IX Diseases of the circulatory system,I9_STR,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,0.97 [0.78-1.21],0.783237846075849,trans
Chapter IX Diseases of the circulatory system,I9_STR,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.98 [0.86-1.12],0.783451750903003,trans
Chapter IX Diseases of the circulatory system,I9_STR,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.95 [0.67-1.35],0.786842627651292,trans
Chapter IX Diseases of the circulatory system,I9_STR,GAST,Gastrin,Inverse variance weighted,9,0.99 [0.89-1.1],0.791749275020717,trans
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.01 [0.96-1.05],0.797384236956829,trans
Chapter IX Diseases of the circulatory system,I9_STR,GUCA2A,Guanylin,Inverse variance weighted,7,0.98 [0.85-1.13],0.800906078196159,trans
Chapter IX Diseases of the circulatory system,I9_STR,LMNB2,Lamin-B2,Inverse variance weighted,8,0.98 [0.81-1.17],0.804079797826591,trans
Chapter IX Diseases of the circulatory system,I9_STR,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,1.03 [0.83-1.27],0.804868888459044,trans
Chapter IX Diseases of the circulatory system,I9_STR,LAYN,Layilin,Inverse variance weighted,3,1.07 [0.61-1.88],0.812691135926649,trans
Chapter IX Diseases of the circulatory system,I9_STR,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,0.99 [0.94-1.05],0.816016191211322,trans
Chapter IX Diseases of the circulatory system,I9_STR,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,1.01 [0.9-1.15],0.81610162630005,trans
Chapter IX Diseases of the circulatory system,I9_STR,INHBB,Inhibin beta B chain,Inverse variance weighted,11,1.02 [0.89-1.16],0.817850422096693,trans
Chapter IX Diseases of the circulatory system,I9_STR,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,0.97 [0.78-1.22],0.819169781193251,trans
Chapter IX Diseases of the circulatory system,I9_STR,SPON2,Spondin-2,Inverse variance weighted,3,1.03 [0.8-1.33],0.82185044180184,trans
Chapter IX Diseases of the circulatory system,I9_STR,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,0.99 [0.89-1.1],0.82354668825454,trans
Chapter IX Diseases of the circulatory system,I9_STR,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,0.97 [0.71-1.32],0.82369655974247,trans
Chapter IX Diseases of the circulatory system,I9_STR,FOLR1,Folate receptor alpha,Inverse variance weighted,6,1.02 [0.87-1.18],0.82653722086302,trans
Chapter IX Diseases of the circulatory system,I9_STR,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.98 [0.84-1.15],0.836485612701073,trans
Chapter IX Diseases of the circulatory system,I9_STR,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.99 [0.92-1.07],0.837602139830429,trans
Chapter IX Diseases of the circulatory system,I9_STR,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,1.01 [0.9-1.14],0.83829570910224,trans
Chapter IX Diseases of the circulatory system,I9_STR,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,1.01 [0.92-1.11],0.84184403086124,trans
Chapter IX Diseases of the circulatory system,I9_STR,DPT,Dermatopontin,Inverse variance weighted,4,0.96 [0.63-1.47],0.84676868919556,trans
Chapter IX Diseases of the circulatory system,I9_STR,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.97 [0.74-1.28],0.852198648983319,trans
Chapter IX Diseases of the circulatory system,I9_STR,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,0.99 [0.93-1.06],0.853264090405065,trans
Chapter IX Diseases of the circulatory system,I9_STR,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.02 [0.8-1.32],0.853680119074506,trans
Chapter IX Diseases of the circulatory system,I9_STR,HGF,Hepatocyte growth factor,Inverse variance weighted,5,1.02 [0.85-1.22],0.859841004653914,trans
Chapter IX Diseases of the circulatory system,I9_STR,CST3,Cystatin-C,Inverse variance weighted,3,1.03 [0.72-1.49],0.860742817035301,trans
Chapter IX Diseases of the circulatory system,I9_STR,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,0.98 [0.76-1.26],0.861572738602351,trans
Chapter IX Diseases of the circulatory system,I9_STR,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,0.99 [0.91-1.09],0.866259896020496,trans
Chapter IX Diseases of the circulatory system,I9_STR,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,0.99 [0.85-1.15],0.868306460246399,trans
Chapter IX Diseases of the circulatory system,I9_STR,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,1.02 [0.81-1.29],0.870044067423374,trans
Chapter IX Diseases of the circulatory system,I9_STR,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,0.99 [0.86-1.14],0.902515409535036,trans
Chapter IX Diseases of the circulatory system,I9_STR,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,1 [0.92-1.08],0.904101777166434,trans
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.98 [0.65-1.46],0.904305972693108,trans
Chapter IX Diseases of the circulatory system,I9_STR,NECTIN4,Nectin-4,Inverse variance weighted,4,0.99 [0.79-1.23],0.908306051049611,trans
Chapter IX Diseases of the circulatory system,I9_STR,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.98 [0.63-1.51],0.91711401955707,trans
Chapter IX Diseases of the circulatory system,I9_STR,FAM3B,Protein FAM3B,Inverse variance weighted,26,1 [0.96-1.03],0.918479101977815,trans
Chapter IX Diseases of the circulatory system,I9_STR,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,1.01 [0.86-1.19],0.918779315413096,trans
Chapter IX Diseases of the circulatory system,I9_STR,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,1.02 [0.75-1.38],0.921261212478324,trans
Chapter IX Diseases of the circulatory system,I9_STR,GCG,Pro-glucagon,Inverse variance weighted,2,0.99 [0.74-1.32],0.921916388711889,trans
Chapter IX Diseases of the circulatory system,I9_STR,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,1 [0.96-1.05],0.922141793970748,trans
Chapter IX Diseases of the circulatory system,I9_STR,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,1.02 [0.74-1.4],0.923591145151125,trans
Chapter IX Diseases of the circulatory system,I9_STR,GDF15,Growth/differentiation factor 15,Wald ratio,1,1.03 [0.59-1.8],0.923975246501981,trans
Chapter IX Diseases of the circulatory system,I9_STR,DLL1,Delta-like protein 1,Inverse variance weighted,6,0.99 [0.83-1.18],0.929231180505878,trans
Chapter IX Diseases of the circulatory system,I9_STR,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.01 [0.86-1.17],0.930020055626476,trans
Chapter IX Diseases of the circulatory system,I9_STR,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,1 [0.91-1.11],0.933542414166535,trans
Chapter IX Diseases of the circulatory system,I9_STR,NUCB2,Nucleobindin-2,Inverse variance weighted,2,1.01 [0.75-1.37],0.934493897528621,trans
Chapter IX Diseases of the circulatory system,I9_STR,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,1 [0.95-1.05],0.934816081282078,trans
Chapter IX Diseases of the circulatory system,I9_STR,VWC2,Brorin,Inverse variance weighted,12,0.99 [0.84-1.18],0.941310565658673,trans
Chapter IX Diseases of the circulatory system,I9_STR,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.02 [0.65-1.59],0.943981294758274,trans
Chapter IX Diseases of the circulatory system,I9_STR,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,0.99 [0.86-1.15],0.944608940646249,trans
Chapter IX Diseases of the circulatory system,I9_STR,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,1 [0.96-1.04],0.949231311375784,trans
Chapter IX Diseases of the circulatory system,I9_STR,OGN,Mimecan,Inverse variance weighted,37,1 [0.96-1.04],0.952370946588653,trans
Chapter IX Diseases of the circulatory system,I9_STR,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,0.99 [0.78-1.26],0.952592825963621,trans
Chapter IX Diseases of the circulatory system,I9_STR,IMMT,MICOS complex subunit MIC60,Wald ratio,1,0.99 [0.72-1.38],0.960893087912714,trans
Chapter IX Diseases of the circulatory system,I9_STR,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,1.01 [0.78-1.29],0.963079645324665,trans
Chapter IX Diseases of the circulatory system,I9_STR,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,1 [0.85-1.19],0.963891817516936,trans
Chapter IX Diseases of the circulatory system,I9_STR,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,1 [0.87-1.16],0.965219969747411,trans
Chapter IX Diseases of the circulatory system,I9_STR,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1 [0.88-1.14],0.965337524457236,trans
Chapter IX Diseases of the circulatory system,I9_STR,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,1 [0.9-1.1],0.966392860656365,trans
Chapter IX Diseases of the circulatory system,I9_STR,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,1.01 [0.7-1.44],0.968381355469462,trans
Chapter IX Diseases of the circulatory system,I9_STR,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1 [0.87-1.15],0.971423594737451,trans
Chapter IX Diseases of the circulatory system,I9_STR,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,1 [0.94-1.07],0.977108410523304,trans
Chapter IX Diseases of the circulatory system,I9_STR,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,1 [0.88-1.13],0.978539581042361,trans
Chapter IX Diseases of the circulatory system,I9_STR,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,1 [0.9-1.11],0.979250522155268,trans
Chapter IX Diseases of the circulatory system,I9_STR,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1 [0.84-1.2],0.985401768238183,trans
Chapter IX Diseases of the circulatory system,I9_STR,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1 [0.69-1.43],0.99007231476657,trans
Chapter IX Diseases of the circulatory system,I9_STR,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,1 [0.69-1.45],0.998363859296157,trans
